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The finding that the mast cell can play an important role
in innate immunity to bacteria reopens the question of
the true role of this controversial cell in the immune
system.
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Mast cells comprise a heterogeneous family of cell types
derived from the bone marrow, which are mainly found res-
ident in the connective tissues of the skin, lung and gut.
Their common feature is prominent cytoplasmic granules
containing heparin, histamine and proteases, which can be
released — a process known as degranulation — into the
tissues when the cells are appropriately activated. Tradi-
tionally, mast cells have been perceived as belonging to the
effector arm of the immune system, and as coming into
action at the end stage of an immune response or as part of
the memory response. This is because of the apparent need
for the mast cell to be ‘armed’, via specific surface recep-
tors, with antigen-specific immunoglobulins (of classes E or
G) from a previous immune response before it can react to
parasite antigens.
Although the degranulation of mast cells at sites of meta-
zoan parasite invasion is protective for the host, mast cell
degranulation is more commonly associated in the clinical
situation with adverse, sometimes fatal, reactions to harm-
less environmental allergens. This view of the mast cell
has begun to change with the recent evidence that mast
cells can also synthesize and release key immunoregula-
tory cytokines — interleukin-3 (IL-3), IL-4, IL-5, IL-6,
IL-8 and tumor necrosis factor-a (TNF-a) [1,2] — and be
phagocytic towards bacteria [3,4]. These findings have
given rise to the speculation that mast cells could be
involved in regulation or fine tuning of the immune
response, either as a negative-feedback mechanism or a
form of T-cell independent help for B cells.
Two recent papers [5,6] have pushed the redemption of
the mast cell as a proactive force in the immune response
a further step forward. Both groups of researchers used the
mast cell deficient W/Wv mouse strain, which lacks the
receptor for stem cell factor (SCF), an important growth
factor for mast cell progenitors and other blood cell types.
Malaviya et al. [6] found that, compared with normal mice,
the mast-cell deficient W/Wv mouse strain was not able to
clear efficiently either an intranasal or intraperitoneal
infection with pathogenic Klebsiella pneumoniae. This
defect was correlated with an impaired ability to produce
TNF-a and recruit neutrophils to the site of infection.
This in itself was not proof that the lack of mast cells was
responsible for the decreased rate of bacterial clearance
from the tissues, as these mice also have reduced numbers
of other blood cell types. However, reconstitution of the
W/Wv mice with purified mast cells from normal mice
brought the bacterial clearance rates back to normal levels
and restored the production of early high levels of TNF-a
and the recruitment of neutrophils into the infection site.
Notably, the key bacterial component of the Klebsiella
pneumoniae to which the mast cells responded was a minor
subunit of type 1 fimbriae, a protein known as FimH.
The second paper, by Echtenacher et al. [5], also involved
the use of mast-cell deficient W/Wv mice, this time in a
model of acute septic peritonitis induced by surgical
caecum ligation and puncture. When this procedure was
performed in the mast-cell deficient W/Wv mice, a striking
100 % mortality occurred, compared with the 25 % mortal-
ity in littermate control mice. Reconstitution of W/Wv
mice with bone-marrow-derived mast cells before surgery
appeared to protect the W/Wv mice from the lethal conse-
quences of the caecum ligation and puncture procedure.
Echtenacher et al. [5] suggested that the mast-cell effect
was mediated by TNF-a, because the injection of anti-
TNF-a neutralizing antibodies suppressed the mast-cell-
mediated protection, while injection of a single dose of
TNF-a protected unreconstituted W/Wv mice from the
caecum ligation and puncture procedure.
Taken together, these two papers [5,6] demonstrate that
mast cells play an important early role in the immune
response against Gram-negative bacteria. The proposed
scenario involves pathogenic bacteria invading tissues and
directly activating mast cells to release stored TNF-a [7].
The released TNF-a induces the rapid recruitment of
neutrophils to the site of infection, resulting in the early
clearance of bacteria. Even though this is a compelling
model, it remains to be clearly established whether there
are functionally distinct mast-cell subtypes which can
respond to bacterial components in this way, and which of
these mast-cell subtypes are the primary source of TNF-a. 
Conventionally, mast cells have been divided into two
types, mucosal-type mast cells and connective-tissue mast
cells, based on differences in their granule proteases and
the growth factors that drive their development. Mucosal
mast cells express low levels of histamine and are regulated
by T-cell derived IL-3 for their growth. Connective tissue
mast cells are not T-cell dependent, but require SCF and
other growth factors. Human mast cells can be divided into
a tryptase-containing type (MCT) found in the mucosa,
and a tryptase- and chymotryptase-containing type
(MCTC) found in the connective tissue [8]. MCTC cells
release histamine in response to immunological agents —
antigen and immunoglobulin E — as well as to a wide
variety of non-immunological agents, such as the bacterial-
derived formyl-methionine-containing peptides, substance
P and the anaphylatoxin C5a. MCT cells appear to be T-
cell dependent, with reduced numbers being found in
immunodeficient patients, and are activated exclusively by
immunoglobulin-E-dependent mechanisms [9]. Such dif-
ferences could reflect the specialization of different mast-
cell subsets for bacterial or parasitic infections, that is to say
for innate versus adaptive immune responses.
The important questions that still need to be answered
include that of whether the mast-cell preparations used for
the reconstitution experiments discussed above contained
significant numbers of contaminating haemopoietic cell
types, which could be a source of TNF-a during the infec-
tion. Furthermore, it needs to be determined whether the
mast cells only recruit neutrophils to the site of infection, or
whether other cells could be contributing to the clearance
of the bacteria in these experiments. It is also important to
determine what other bacterial/protozoan and metazoan
components the mast cell can respond to in addition to type
1 fimbriae from Gram-negative bacteria.
In the light of these new findings, the role of the mast cell
in host immune responses deserves to be reconsidered
(Fig. 1). The ability of mast cells to store and rapidly
secrete TNF-a and recruit neutrophils to sites of infection,
allied with their tissue distribution at all skin and mucosal
sites, now places mast cells as an important and necessary
first line of defence against bacterial infection. This role is
in addition to the clear role of mast cells in acquired immu-
nity to parasitic infections, and involvement in allergic
reactions to environmental antigens. It is not clear whether
the TNF-a-producing mast cells involved in the innate
anti-bacterial response are the same as those which
mediate the allergic inflammatory reactions or produce
immunoregulatory cytokines. 
It will be important to determine which microbial compo-
nents stimulate mast cells, and whether they stimulate the
release of various subsets of mast-cell products. One possi-
bility is that metazoan parasites do not have molecular com-
ponents that can directly stimulate mast-cell mediator
release, or have evolved means to avoid doing so. As a con-
sequence, the immunoglobulin E arm of the adaptive
immune system may have evolved as a mechanism to
restore the host’s ability to respond immediately to invading
parasites. These questions represent an exciting and impor-
tant challenge to immunologists and future work aimed at
addressing them should lead to more detailed insight into
how the immune system is organized and has evolved.
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Figure 1
Pathways involving mast cells that lead to an inflammatory response.
The diagram outlines both the direct (innate) and indirect (acquired)
mechanisms for triggering mast-cell degranulation. At this stage it is
not clear whether there are specialized subsets of mast cells for
dealing with different types of infectious agent or mediating different
kinds of inflammatory reaction; because of this uncertainty, the figure
shows the mast-cell population consisting of two or more, possibly
overlapping subtypes.
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